September 09, 2019 World Lung 2019 – Oncimmune’s liquid biopsy hits in large trial The data are positive, but might not do much for the company’s sales.
April 25, 2019 Deals and data in the offing for Oncimmune Oncimmune is not the only company looking to use the immune system to diagnose cancer. But its growth plans are intense, and it intends to prove the economic benefits of its tests.
